"Increases in GLP-1RA dispensing were greatest for females, highlighting the importance of educating patients and prescribers on sex-specific safety risks [eg, concerns during pregnancy]," the team noted
Because it does not engage the GH receptor, the expected side-effect domain is limited to the adipose compartment
470 One could argue that the success of sodium-glucose cotransporter 2 (SGLT2) inhibitors, and now of GLP-1RAs, suggests that metabolic abnormalities play an important role in driving HFpEF
Rushing this process, skipping dose levels, or starting at a higher dose to accelerate weight loss dramatically increases side effect severity
Results are progressive the body continues to eliminate disrupted fat cells naturally over several weeks following each session
Intracellular concentrations of 4HNE may be critical for cells 13